• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新兴的化疗靶点:胶质瘤治疗进展的见解

Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment.

作者信息

Rezk Rogina, Hanna Abanob George, Hutchinson Hunter, Farag Mariam, Lucke-Wold Brandon

机构信息

College of Medicine, University of Florida, Gainesville, FL 32610, USA.

Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.

出版信息

Biomedicines. 2025 Jun 12;13(6):1452. doi: 10.3390/biomedicines13061452.

DOI:10.3390/biomedicines13061452
PMID:40564171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12190830/
Abstract

Primary brain tumors represent a significant focus of contemporary research. With advancements in technology and the increasing detection of cases through novel diagnostic methods, innovative therapies and approaches to chemotherapy continue to emerge. The paper explores recent advancements in chemotherapy for glioblastoma, highlighting innovative approaches that provide valuable mechanistic insights. It delves into the mechanisms of action, molecular targets, and the future potential of emerging therapies for gliomas. Additionally, this paper offers an overview investigating a range of therapies, including various chemotherapeutic agents, CAR-T cell therapies, drugs targeting cellular respiration, and other approaches. Furthermore, the paper addresses chemotherapy-related challenges, including the blood-brain barrier, drug resistance, and immunosuppression, while proposing potential solutions to overcome these obstacles.

摘要

原发性脑肿瘤是当代研究的一个重要焦点。随着技术的进步以及通过新型诊断方法对病例检测的增加,创新疗法和化疗方法不断涌现。本文探讨了胶质母细胞瘤化疗的最新进展,重点介绍了提供有价值机制见解的创新方法。它深入研究了神经胶质瘤新兴疗法的作用机制、分子靶点和未来潜力。此外,本文还概述了一系列疗法的研究,包括各种化疗药物、嵌合抗原受体T细胞(CAR-T)疗法、针对细胞呼吸的药物以及其他方法。此外,本文还讨论了化疗相关的挑战,包括血脑屏障、耐药性和免疫抑制,同时提出了克服这些障碍的潜在解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b97/12190830/f3a3e1835f00/biomedicines-13-01452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b97/12190830/b76da1503513/biomedicines-13-01452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b97/12190830/f3a3e1835f00/biomedicines-13-01452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b97/12190830/b76da1503513/biomedicines-13-01452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b97/12190830/f3a3e1835f00/biomedicines-13-01452-g002.jpg

相似文献

1
Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment.新兴的化疗靶点:胶质瘤治疗进展的见解
Biomedicines. 2025 Jun 12;13(6):1452. doi: 10.3390/biomedicines13061452.
2
Accreditation through the eyes of nurse managers: an infinite staircase or a phenomenon that evaporates like water.护士长眼中的认证:是无尽的阶梯还是如流水般消逝的现象。
J Health Organ Manag. 2025 Jun 30. doi: 10.1108/JHOM-01-2025-0029.
3
Emerging nanoparticle-based strategies to provide therapeutic benefits for stroke.基于纳米颗粒的新兴策略为中风提供治疗益处。
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01492.
4
Wood Waste Valorization and Classification Approaches: A systematic review.木材废料的增值与分类方法:一项系统综述
Open Res Eur. 2025 May 6;5:5. doi: 10.12688/openreseurope.18862.1. eCollection 2025.
5
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges.外泌体作为用于脑靶向递送治疗性核酸的纳米载体:进展与挑战
J Nanobiotechnology. 2025 Jun 18;23(1):453. doi: 10.1186/s12951-025-03528-2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
8
Medulloblastoma: Molecular Targets and Innovative Theranostic Approaches.髓母细胞瘤:分子靶点与创新诊疗方法
Pharmaceutics. 2025 Jun 4;17(6):736. doi: 10.3390/pharmaceutics17060736.
9
Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.胶质母细胞瘤免疫治疗:现有策略的系统评价及进展展望。
Int J Mol Sci. 2023 Oct 10;24(20):15037. doi: 10.3390/ijms242015037.
10
Radiotherapy for diffuse brainstem glioma in children and young adults.儿童和青年弥漫性脑干胶质瘤的放射治疗
Cochrane Database Syst Rev. 2016 Jun 27;2016(6):CD010439. doi: 10.1002/14651858.CD010439.pub2.

本文引用的文献

1
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma.胶质母细胞瘤抗血管生成疗法耐药机制中的最新治疗策略和分子途径
Cancers (Basel). 2024 Aug 27;16(17):2975. doi: 10.3390/cancers16172975.
2
Exosome-based nanoparticles and cancer immunotherapy.基于外泌体的纳米颗粒与癌症免疫治疗。
Biomed Pharmacother. 2024 Oct;179:117296. doi: 10.1016/j.biopha.2024.117296. Epub 2024 Aug 20.
3
Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma.
干扰素调节因子8驱动的免疫微环境重编程增强了小鼠胶质母细胞瘤的抗肿瘤适应性免疫并减少了免疫抑制。
Neuro Oncol. 2024 Dec 5;26(12):2272-2287. doi: 10.1093/neuonc/noae149.
4
Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme-A Literature Review and Clinical Outcomes.替莫唑胺(TMZ)治疗多形性胶质母细胞瘤:文献回顾与临床结局。
Curr Oncol. 2024 Jul 12;31(7):3994-4002. doi: 10.3390/curroncol31070296.
5
HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo.HER2 靶向 CAR-T 细胞在体外和体内均对胶质母细胞瘤表现出高效的抗肿瘤活性。
Genes Immun. 2024 Jun;25(3):201-208. doi: 10.1038/s41435-024-00275-6. Epub 2024 May 3.
6
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.表观遗传重塑以提高人类胶质母细胞瘤免疫治疗的疗效:开发新免疫治疗方法的临床前证据。
J Transl Med. 2024 Mar 1;22(1):223. doi: 10.1186/s12967-024-05040-x.
7
Endothelial cells in tumor microenvironment: insights and perspectives.肿瘤微环境中的内皮细胞:深入了解和展望。
Front Immunol. 2024 Feb 15;15:1367875. doi: 10.3389/fimmu.2024.1367875. eCollection 2024.
8
Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities.表皮生长因子受体抑制剂在脑胶质瘤中的应用:现状与未来可能。
Int J Mol Sci. 2024 Feb 15;25(4):2316. doi: 10.3390/ijms25042316.
9
Causal Association of Cytokines and Growth Factors with Stroke and Its Subtypes: a Mendelian Randomization Study.细胞因子和生长因子与中风及其亚型的因果关系:一项孟德尔随机化研究。
Mol Neurobiol. 2024 Jun;61(6):3212-3222. doi: 10.1007/s12035-023-03752-7. Epub 2023 Nov 18.
10
Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme-a retrospective cohort study.血浆 PD-L1 作为多形性胶质母细胞瘤临床管理的生物标志物:一项回顾性队列研究。
Front Immunol. 2023 Jul 17;14:1202098. doi: 10.3389/fimmu.2023.1202098. eCollection 2023.